Tag: Coronavirus Vaccine

Phase III Trial Of Bharat Biotech Intranasal Vaccine
DGCI Approves For Phase III Trial Of Bharat Biotech Intranasal Vaccine As Booster

According to a source, Bharat Biotech aims to conduct clinical trials on 5,000 healthy subjects: half or 2,500 individuals who have received Covishield and another 2,500 who have been administered Covaxin.

  • Wednesday, 05 January 2022
Centre To Procure 60L DNA Vaccines In October
Centre To Procure 60L DNA Vaccines In October

The three-dose DNA built vaccine has 66.6 per cent efficacy against Covid.

  • Wednesday, 13 October 2021
COVID-19 Vaccine
Over 88.14 Crore COVID-19 Vaccine Doses Given To States, Uts: Health Ministry

As part of the nationwide vaccination drive, the government has been supporting states and UTs by providing them COVID-19 vaccines for free, the ministry said.

  • Saturday, 02 October 2021
Covid-19 Vaccine
Over 79.58 Crore COVID-19 Vaccine Doses Provided To States, UTs: Centre

As part of the nationwide vaccination drive, the Centre has been supporting the states and UTs by providing them COVID-19 vaccines free of cost.

  • Monday, 20 September 2021
Covid Vaccination In Odisha
Odisha Issues Guidelines For Special Covid Vaccination Campaign For Teachers, School Staff

The Odisha government has released a set of guidelines for the launch of a special Covid vaccination campaign for teachers and non-teaching staff of schools across the State.

  • Saturday, 28 August 2021
COVID19 Vaccine
Covid 3rd Wave May See Half The Cases Recorded During Second Surge, Says Govt Panel Scientist

A possible third wave of coronavirus infection can hit its peak between October-November if Covid-appropriate behaviour is not followed, but it may see half the daily cases recorded during the second surge, said a scientist of a government panel tasked with modelling of COVID-19 cases.

  • Sunday, 04 July 2021
More Than 23 Crore COVID19 Vaccine Doses Provided To States/UTs
Adequate COVID19 Vaccines From August Onward: NITI Aayog CEO

"From then on, we should be able to vaccinate everybody in India properly and that should help us," he said, amid a shortage of vaccine in various states.

  • Thursday, 03 June 2021
COVID-19 Vaccine
Second Made-In-India Vax Coming, Deal Signed For 30 Cr Doses

Biological-E's vaccine is currently in Phase-3 clinical trials after showing promising results in Phase 1 and 2, and it is likely to be available in the market in next few months, said a Ministry of Health and Family Welfare (MoHFW) statement.

  • Thursday, 03 June 2021
Odisha CM Sanctions Additional Funds To 3 Dists For Covid Managament Bhubaneswar: In order to manage the rising Covid-19 situation, Chief Minister Naveen Patnaik on Thursday sanctioned additional funds for three districts-Puri, Sonepur and Sambalpur- from the chief Minister Relief Funds (CMRF). Puri district which had earlier received of Rs 14,59,74,408 from the government, was sanctioned additional further from CMRF. With the additional amount, Puri district now has received a total Rs 16,59,74,408  for Covid management. Similarly, the Chief Minister has also sanctioned Rs 1 Crore for Sonepur district, which was given 2,50,00,000 earlier. With Rs 1 crore additional funds, the total amount sanctioned to the district went up to 3,50,00,000 for Covid-19 management. Similarly, Sambalpur district received a total Rs 16,12,80,692 with additional fund of Rs 4,62,80,692 released today from the CMRF. The government had previously sanctioned Rs 11,50,00,000 for the district to spend on Covid management.
Naveen Writes To All CMs, Pushes For Centralised Procurement Of Covid-19 Vaccines

Odisha CM Naveen Patnaik said though many states have floated global tenders for vaccine procurement, the global vaccine manufacturers are looking forward to the Union Government for the clearances and assurances.

  • Wednesday, 02 June 2021
Covaxin Price Slashed To Rs 400/Dose For States
Production Batches Of Covaxin Initiated In March To Be Ready Only In June

For vaccines to result in actual vaccination of people, highly coordinated efforts are required from international supply chain, manufacturers, regulators, and state and Central government agencies, it added.

  • Friday, 28 May 2021
New Antiviral With 99.9% Efficacy Against Covid-19 Developed
New Antiviral With 99.9% Efficacy Against Covid-19 Developed

The new antiviral approach used gene-silencing RNA technology called siRNA (small-interfering RNA) to attack the virus' genome directly, which stops the virus from replicating, as well as lipid nanoparticles designed at Griffith University and City of Hope to deliver the siRNA to the lungs, the critical site of infection.

  • Wednesday, 19 May 2021
COVID19 vaccine
Mixing Covid Vaccine Doses Safe, Can Raise Side Effects: Lancet

Mixing Covid-19 vaccine doses -- second dose from a different brand than the first -- is safe, but may present more frequent mild side-effects such as a headache, chills or a fever, showed results of a preliminary study published in the Lancet.

  • Friday, 14 May 2021
UK Donates $26mn To Speed Up Coronavirus Vaccine

London: The UK government has donated 20 million pounds ($26 million) towards a break-neck plan to produce a vaccine to combat the deadly new coronavirus, which has till Monday claimed the lives of 361 people in China alone. On Sunday, Health Secretary Matt Hancock said that government’s investment will go to CEPI – the Coalition […]

  • Tuesday, 20 April 2021
Coronavirus Vaccine May Still Be A Year Away: Australia Varsity

New Delhi: A scientist involved in developing a coronavirus vaccine at Australia’s University of Queensland has said that it may take about one year before people will actually be able to use it. The Coalition for Epidemic Preparedness Innovations (CEPI), a partnership against epidemics by public, private, philanthropic, and civil organisations earlier commissioned the University […]

  • Monday, 19 April 2021
Researchers Develop Coronavirus Vaccine Candidate

Sydney: A team of researchers at the University of Queensland in Australia has created their first vaccine candidate in the laboratory for the novel coronavirus, COVID-19. The team will move immediately into further development before formal pre-clinical testing, the university said on Friday. The proof-of-concept milestone comes in less than a month after the project’s […]

  • Monday, 19 April 2021